Golden Developing Solutions, Inc.
DVLP
Other OTC0.00
USD
- -
- -
CIK
0001736865
ISIN
US38089W1036
CUSIP
38089W103
Return %
Stock
S&P500
1Y
-90.00
18.86
3Y
-98.00
64.57
5Y
-99.92
71.65
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Stavros A. Triant
- Full Time Employees
- 53
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- PO Box 460573 Fort Lauderdale FL United States of America 33346
- IPO Date
- Sep 8, 2016
- CIK
- 0001736865
- Website
- goldendeveloping.com
- Similar Companies
- Business
- Golden Developing Solutions, Inc. is a development-stage public company primarily engaged in the health and wellness sector, focusing on the production and distribution of nutritional supplements including vitamins, tinctures, softgels, and topical application products as well as cannabidiol (CBD) and hemp oil-based products. The company operates through its wholly owned subsidiary Pura Vida Vitamins and extends its offerings via wholesale and distribution channels. It also incorporates a pharmaceutical division specializing in specialty medicines with rapid delivery and medical support services, primarily serving the United States, with a growing presence in the states of Michigan and Florida through recent acquisitions. Founded in 1998 and headquartered in Fort Lauderdale, Florida, Golden Developing Solutions has pursued an aggressive acquisition strategy, completing four specialty pharmacy acquisitions in 2022—Orchard Trails Pharmacy, New Hudson Pharmacy, Bushnell Pharmacy, and Sai Siva Healthcare—projecting combined revenues of approximately $100 million annually, with plans to close two additional acquisitions potentially doubling revenue estimates to over $200 million. The company has focused on enhancing transparency and communication, updating its website and media strategy to provide better investor and public information. Recent corporate actions since mid-2025 include capital restructuring through debt conversions, minority equity investments, and equity issuances. Despite past financial difficulties including a Chapter 11 bankruptcy filing in mid-2023 related to regulatory challenges and operational risks, Golden Developing Solutions continues to build infrastructure and expand through synergistic acquisitions in health, wellness, and technology sectors, positioning itself as a comprehensive provider of health-related products and specialty pharmacy services in the U.S. market.
Golden Developing Solutions Inc (OTC:DVLP) Discusses Positive Strategic Move To Protect Shareholder Equity